---
title: "Prader-Willi Syndrome Observational Study of VYKAT™ XR C623 | Sutter Health"
description: "An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)"
url: "https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research studies](https://www.sutterhealth.org/research/studies) /
4.  Prader-Willi Syndrome Observational Study of VYKAT™ XR C623

# Prader-Willi Syndrome Observational Study of VYKAT™ XR C623

An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)

![Niyati Skaria, M.D.](https://dyn.mktgcdn.com/p/onSkTDtymp9DfCXYgWUHxIte2vKo1K-mtIKAypB3J5o/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100)

Niyati Skaria, M.D.

Principal investigator

[View profile](https://www.sutterhealth.org/research/investigators/niyati-skaria-md-2044047632)

## Research topics

-   [All Endocrinology](https://www.sutterhealth.org/research-search-results?query=%22%5C%22All+Endocrinology%5C%22%22)
-   [Prader-Willi Syndrome (PWS)](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Prader-Willi+Syndrome+%28PWS%29%5C%22%22)

## Related studies

[View all studies](https://www.sutterhealth.org/research/studies)

-   Research study
    
    ### [Growth Hormone Deficiency SkyPass](https://www.sutterhealth.org/research/studies/diabetes-endocrinology-skypass-1078067743)
    
    A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin (SkyPASS)
    
-   Research study
    
    ### [Growth Hormone Deficiency SkybriGHt](https://www.sutterhealth.org/research/studies/diabetes-endocrinology-skybright-1078067748)
    
    A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA (SkybriGHt)
    

[View all studies](https://www.sutterhealth.org/research/studies)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research studies","item":"https://www.sutterhealth.org/research/studies"},{"@type":"ListItem","position":4,"name":"Prader-Willi Syndrome Observational Study of VYKAT™ XR C623"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979#medicalwebpage","name":"Prader-Willi Syndrome Observational Study of VYKAT™ XR C623","description":"An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)","url":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979","inLanguage":"en-US","dateModified":"2026-07-06","publisher":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"medicalAudience":{"@type":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979#medicalobservationalstudy"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979#breadcrumblist"},"mentions":[{"@type":"Person","@id":"https://www.sutterhealth.org/find-provider/dr-niyati-skaria-1046241093#Person","name":"Niyati Skaria, M.D.","url":"https://www.sutterhealth.org/research/investigators/niyati-skaria-md-2044047632","sameAs":"https://www.sutterhealth.org/find-provider/dr-niyati-skaria-1046241093"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalObservationalStudy","@id":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979#medicalobservationalstudy","name":"Prader-Willi Syndrome Observational Study of VYKAT™ XR C623","alternateName":"Prader-Willi Syndrome Observational Study of VYKAT™ XR C623","url":"https://www.sutterhealth.org/research/studies/prader-willi-syndrome-observational-study-of-vykat-xr-c623-2072227979","description":"An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)","healthCondition":[{"@type":"MedicalCondition","name":"All Endocrinology"},{"@type":"MedicalCondition","name":"Prader-Willi Syndrome (PWS)"}]}
```